Because identifying and communicating with patients who are willing to participate in trials can be a significant challenge, Synexus says it is keen to adopt a streamlined process that offers consistency across multiple channels.
Synexus, a site management organization headquartered in Manchester, UK, has appointed business process management company Firstsource Solutions to review and support its strategy for communicating with patients across the United Kingdom. The aim is to create real-time responsiveness and dialogue, leading to an enhanced patient experience throughout the clinical trial process, according to the company.
Because identifying and communicating with patients who are willing to participate in trials can be a significant challenge, Synexus says it is keen to adopt a streamlined process that offers consistency across multiple channels and builds awareness and understanding of the benefits that clinical research can bring for patients, leading to better engagement.
“We selected Firstsource as our partner of choice because of the significant experience they have with major consumer brands that are highly sophisticated when it comes to adopting a multi-channel approach,” noted Sarah Beeby, VP Global Strategic Service Development at Synexus. “We hope to learn from their experiences and apply these to develop a communications strategy that will boost the awareness of clinical trials.”
Targeted messaging of engaging content across various platforms will boost understanding of the benefits of clinical trial participation, and these benefits will carry through the life of the trial by ensuring participants feel well informed and stay motivated to the end of the study, she added.
“In today’s multi-channel world, multiple touch points are becoming a business necessity rather than a ‘nice to have’, and the health sector is no exception,” said Gavin Snell, President, Customer Management, Firstsource Solutions. “Whilst Synexus has offered numerous engagement opportunities to its patients this project will take the business to the next level and really transform the patient experience.”
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.